What is the current Five Prime Therapeutics market capitalization?
The current market capitalization of Five Prime Therapeutics is 1.4 B USD.
Five Prime Therapeutics Market capitalization 2024
Five Prime Therapeutics Market capitalization
1.4 B USD
Ticker
FPRX
ISIN
US33830X1046
WKN
A1W5T9
In 2024, Five Prime Therapeutics's market cap stood at 1.4 B USD, a 1,104.06% increase from the 116.25 M USD market cap in the previous year.
The Five Prime Therapeutics Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2020 | 0.24 |
| 2019 | 0.26 |
| 2018 | 0.54 |
| 2017 | 0.97 |
| 2016 | 1.2 |
| 2015 | 0.69 |
| 2014 | 0.32 |
Five Prime Therapeutics Aktienanalyse
What does Five Prime Therapeutics do?
Five Prime Therapeutics Inc. is a biotech company based in South San Francisco, California. It specializes in the discovery and development of innovative therapeutics for serious diseases. The company was founded in 2001 by leading biotechnology researchers and has undergone several mergers and acquisitions. It is currently listed on the Nasdaq stock exchange under the ticker symbol "FPRX". Five Prime Therapeutics' business model is based on the discovery and development of therapeutics for diseases that have been inadequately treated. The company focuses on precision medicine approaches tailored to the individual needs of patients. Its main areas of focus include cancer therapies, inflammatory diseases, and rare genetic diseases. To achieve these goals, the company utilizes a wide range of therapeutic platforms, including antibodies, biologics, and protein therapies. These platforms are based on a deeper understanding of disease processes and mechanisms, as well as a precise understanding of biological and molecular connections in the human body. Five Prime Therapeutics also utilizes artificial intelligence and machine learning in the development of new therapeutics. The company has four main divisions: oncology, immunology, women's health, and genomics/proteomics. Each division focuses on specific indications and development programs. Some key developments and products in each division include: - Oncology: Five Prime Therapeutics has a broad pipeline of precision oncology therapeutics. One of the most important development programs is "FPA150," an antibody targeting B7-H4, a protein expressed by cancer cells. FPA150 is being tested in clinical studies for the treatment of solid tumors and cervical cancer. - Immunology: The company has also developed a pipeline of immunotherapeutics and biologics targeting the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease. One of the key development programs in this area is "FP-028," which targets the TGF-beta signaling pathway. - Women's Health: Five Prime Therapeutics also has a division focused on women's health. An important development program in this area is "FP-1039/GSK3052230," a biologic that could potentially be used for the treatment of ovarian cancer. - Genomics/Proteomics: As the fourth main division, the company is working on biomarker-based therapeutics targeting specific genetic mutations and signaling pathways. An important component of this work is the identification of new target molecules through genomics and proteomics technologies. Overall, Five Prime Therapeutics has achieved an impressive track record in the discovery and development of innovative therapeutics in recent years. Several of its main programs have successfully entered clinical studies and are showing promising results. Additionally, the company has established a successful partnership with GlaxoSmithKline to jointly develop new therapeutics for the treatment of cancer and inflammatory diseases. In summary, Five Prime Therapeutics is an emerging biotech company specialized in the discovery and development of innovative therapeutics for serious diseases. Through its precision medicine business model and wide range of therapeutic platforms, the company has made successful progress in the development of promising therapeutics. Five Prime Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Five Prime Therapeutics's Market Capitalization
Five Prime Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Five Prime Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Five Prime Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Five Prime Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Five Prime Therapeutics stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Five Prime Therapeutics.
How has the market capitalization of Five Prime Therapeutics developed in recent years?
The market capitalization of Five Prime Therapeutics has increased/decreased by 1,104.06% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Five Prime Therapeutics?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Five Prime Therapeutics?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Five Prime Therapeutics have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Five Prime Therapeutics pay?
Over the past 12 months, Five Prime Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Five Prime Therapeutics is expected to pay a dividend of 0 USD.
What is the dividend yield of Five Prime Therapeutics?
The current dividend yield of Five Prime Therapeutics is .
When does Five Prime Therapeutics pay dividends?
Five Prime Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Five Prime Therapeutics?
Five Prime Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Five Prime Therapeutics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Five Prime Therapeutics located?
Five Prime Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Five Prime Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Five Prime Therapeutics from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.
When did Five Prime Therapeutics pay the last dividend?
The last dividend was paid out on 9/29/2024.
What was the dividend of Five Prime Therapeutics in the year 2023?
In the year 2023, Five Prime Therapeutics distributed 0 USD as dividends.
In which currency does Five Prime Therapeutics pay out the dividend?
The dividends of Five Prime Therapeutics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Five Prime Therapeutics
Our stock analysis for Five Prime Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Five Prime Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Five Prime Therapeutics Revenue
- Five Prime Therapeutics Net Income
- Five Prime Therapeutics P/E
- Five Prime Therapeutics P/S
- Five Prime Therapeutics EBIT
- Five Prime Therapeutics Dividend
- Five Prime Therapeutics Stocks
- Five Prime Therapeutics Market capitalization
- Five Prime Therapeutics Debt
- Five Prime Therapeutics Liabilities
- Five Prime Therapeutics Equity
- Five Prime Therapeutics AAQS
- Five Prime Therapeutics Employees
- Five Prime Therapeutics ROE
- Five Prime Therapeutics ROA
- Five Prime Therapeutics ROCE
